235 related articles for article (PubMed ID: 31456143)
1. Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort.
Steindl A; Schlieter F; Klikovits T; Leber E; Gatterbauer B; Frischer JM; Dieckmann K; Widhalm G; Zöchbauer-Müller S; Hoda MAR; Preusser M; Berghoff AS
J Neurooncol; 2019 Oct; 145(1):85-95. PubMed ID: 31456143
[TBL] [Abstract][Full Text] [Related]
2. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
4. Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases.
Steindl A; Yadavalli S; Gruber KA; Seiwald M; Gatterbauer B; Dieckmann K; Frischer JM; Klikovits T; Zöchbauer-Müller S; Grisold A; Hoda MAR; Marosi C; Widhalm G; Preusser M; Berghoff AS
Cancer; 2020 Oct; 126(19):4341-4352. PubMed ID: 32678971
[TBL] [Abstract][Full Text] [Related]
5. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
Bernhardt D; König L; Aufderstrasse S; Krisam J; Hoerner-Rieber J; Adeberg S; Bozorgmehr F; El Shafie R; Lang K; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Marcrom S; Debus J; Steins M; Rieken S
Clin Lung Cancer; 2018 Jul; 19(4):340-345. PubMed ID: 29373273
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
7. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
[TBL] [Abstract][Full Text] [Related]
8. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
9. High Biologically Effective Dose Radiotherapy for Brain Metastases May Improve Survival and Decrease Risk for Local Relapse Among Patients With Small-Cell Lung Cancer: A Propensity-Matching Analysis.
Zhuang QY; Li JL; Lin FF; Lin XJ; -Lin H; -Wang Y; -Lin Y; Huang YX; Zhang XQ; Tang LR; Wu JX
Cancer Control; 2020; 27(2):1073274820936287. PubMed ID: 32614270
[TBL] [Abstract][Full Text] [Related]
10. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer.
Robin TP; Jones BL; Amini A; Koshy M; Gaspar LE; Liu AK; Nath SK; Kavanagh BD; Camidge DR; Rusthoven CG
Lung Cancer; 2018 Jun; 120():88-90. PubMed ID: 29748022
[TBL] [Abstract][Full Text] [Related]
11. Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.
Masel EK; Berghoff AS; Füreder LM; Heicappell P; Schlieter F; Widhalm G; Gatterbauer B; Dieckmann U; Birner P; Bartsch R; Schur S; Watzke HH; Zielinski CC; Preusser M
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28488812
[TBL] [Abstract][Full Text] [Related]
12. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
[TBL] [Abstract][Full Text] [Related]
13. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
[TBL] [Abstract][Full Text] [Related]
14. Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging.
Eze C; Roengvoraphoj O; Niyazi M; Hildebrandt G; Fietkau R; Belka C; Manapov F
Clin Lung Cancer; 2017 Jul; 18(4):e243-e249. PubMed ID: 28065620
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes.
Jiang W; Haque W; Verma V; Butler B; Teh BS
Acta Oncol; 2019 Apr; 58(4):491-498. PubMed ID: 30676131
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
[TBL] [Abstract][Full Text] [Related]
18. Validation of a novel prognostic index: BMS-Score for patients with brain metastases of small cell lung cancer.
Hou R; Li H; Cao J; Song X; Zhang X; Wang W
Ann Palliat Med; 2021 Jan; 10(1):29-36. PubMed ID: 33440957
[TBL] [Abstract][Full Text] [Related]
19. Fractionated stereotactic radiotherapy for small-cell lung cancer patients with brain metastases.
Li XP; Xiao JP; Chen XJ; Jiang XS; Zhang Y; Xu YJ
J Cancer Res Ther; 2014; 10(3):597-602. PubMed ID: 25313746
[TBL] [Abstract][Full Text] [Related]
20. Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score.
Berghoff AS; Wolpert F; Holland-Letz T; Koller R; Widhalm G; Gatterbauer B; Dieckmann K; Birner P; Bartsch R; Zielinski CC; Weller M; Preusser M
Neuro Oncol; 2017 Sep; 19(9):1255-1262. PubMed ID: 28096493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]